Frank Amato

President and CEO, Synaps Dx at SYNAPS Dx - Rockville, MD, us

Frank Amato's Colleagues at SYNAPS Dx
Claudia Johnson

Medical Laboratory Scientist

Contact Claudia Johnson

Julia Cochrane

Medical Laboratory Scientist

Contact Julia Cochrane

Cassie Mitchell

Senior Diagnostic Sales Specialist DISCERN™ - The Alzheimer's Disease Test

Contact Cassie Mitchell

Linda Nguyen

Labratory Operations Support / Lab Safety Officer

Contact Linda Nguyen

Michael Tunkelrott

Vice President Marketing Synaps Dx

Contact Michael Tunkelrott

View All Frank Amato's Colleagues
Frank Amato's Contact Details
HQ
N/A
Location
Bernards,New Jersey,07920,United States
Company
SYNAPS Dx
Frank Amato's Company Details
SYNAPS Dx logo, SYNAPS Dx contact details

SYNAPS Dx

Rockville, MD, us • 20 - 49 Employees
BioTech/Drugs

Synaps Dx has the only minimally invasive highly accurate test, DISCERN™, for Alzheimer's Disease. Multidisciplinary teams at the NIH and the Rockefeller Neurosciences Institute, led by Dr. Alkon, over the last 30 years led to the development of the three biomarkers. The three biomarkers comprise an AD-Index assay, a Morphometric Imaging assay, and a PKC Epsilon assay. FDA has granted SDx Breakthrough Status. Our diagnostic biomarkers have been confirmed by autopsy validation (NIH "Gold Standard").

Biotechnology
Details about SYNAPS Dx
Frequently Asked Questions about Frank Amato
Frank Amato currently works for SYNAPS Dx.
Frank Amato's role at SYNAPS Dx is President and CEO, Synaps Dx.
Frank Amato's email address is ***@ndx-discern.com. To view Frank Amato's full email address, please signup to ConnectPlex.
Frank Amato works in the Research industry.
Frank Amato's phone number is N/A
See more information about Frank Amato